Strong insider buying in last days and many big milestones coming before year end ..Great buying opportunity here https://www.canadianinsider.com/node/7?menu_tickersearch=CPH+%7C+Cipher+Pharmaceuticals Cipher anticipates several key milestones in 2019 that will continue the growth of its Canadian commercial platform, including: *Regulatory approval for plecanatide from Health Canada in Q4 2019 *Regulatory approval for A-101 from Health Canada in Q4 2019 *Commercial launch of XYDALBA (dalbavancin) *North American top line results for MOB-015 in Q4 2019